Is transesophageal echocardiography necessary before electrical cardioversion in patients treated with non-vitamin K antagonist oral anticoagulants? Current evidence and practical approach

According to current guidelines, non-vitamin K antagonist oral anticoagulants (NOACs) should be used at least 3 weeks before planned electrical cardioversion. In accordance with international atrial fibrillation (AF) guidelines, transesophageal echocardiography (TEE) is a pre-procedural examination...

Descripción completa

Detalles Bibliográficos
Autores principales: Gorczyca, Iwona, Uziębło-Życzkowska, Beata, Krzesiński, Paweł, Major, Agnieszka, Kapłon-Cieślicka, Agnieszka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Via Medica 2023
Materias:
Clinical Cardiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10508078/
https://www.ncbi.nlm.nih.gov/pubmed/34671967
http://dx.doi.org/10.5603/CJ.a2021.0129

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10508078/
https://www.ncbi.nlm.nih.gov/pubmed/34671967
http://dx.doi.org/10.5603/CJ.a2021.0129

Ejemplares similares